Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$2.03
-0.04-1.93%
Last update: Oct 2, 7:52 PM
$2.05
-0.02-0.97%
Fortress Biotech Inc (FBIO) Stock Price, Quote, News & History
FBIONASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi,...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Fortress Biotech (NASDAQ:FBIO) through any online brokerage.
Other companies in Fortress Biotech’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Fortress Biotech has a consensus price target of $13.25.
The stock price for Fortress Biotech (NASDAQ: FBIO) is $2.05 last updated October 2, 2026 at 7:52 PM EDT.
There are no upcoming dividends for Fortress Biotech.
Fortress Biotech does not have any upcoming earnings scheduled.
There is no upcoming split for Fortress Biotech.
Fortress Biotech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
